Latest filing published 05 Jan 2016 for Relmada Therapeutics, INC., €915.
Insider track record
No signal scores available.
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -60.0%Entry US$10.80 · Close at T+365 US$4.32
- -81.1%Entry US$13.00 · Close at T+365 US$2.46
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Shreeram Agharkar: trading record in brief
All filings by Shreeram Agharkar on record concern Relmada Therapeutics, Inc. The record holds 3 filings, for trades running from 16 December 2015 to 31 December 2015.
On the market, this insider has only ever bought: 3 purchases, €4,366 in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2016, the count stands at 1 purchase and no sales.
A typical purchase (the median) is worth €915. After 3 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -57.5%. This is a record of the past, not a forecast.
The record was last updated on 5 January 2016 with an open-market purchase (€915) in Relmada Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Shreeram Agharkar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 400 shares@ US$2.50100.0% of flowCommon stockSEC:0001213900-16-009911:0Canonical exit: 30 Mar 2016 (T+90)
- 1,000 shares@ US$3.45Common stockSEC:0001213900-15-009532:0Canonical exit: 15 Mar 2016 (T+90)
- 100 shares@ US$3.25Common stockSEC:0001213900-15-009532:1Canonical exit: 15 Mar 2016 (T+90)
3 of 3 declarations